223 related articles for article (PubMed ID: 29892293)
1. Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase.
Vandooren J; Goeminne P; Boon L; Ugarte-Berzal E; Rybakin V; Proost P; Abu El-Asrar AM; Opdenakker G
Front Immunol; 2018; 9():1154. PubMed ID: 29892293
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo.
Zheng L; Lam WK; Tipoe GL; Shum IH; Yan C; Leung R; Sun J; Ooi GC; Tsang KW
Eur Respir J; 2002 Jul; 20(1):170-6. PubMed ID: 12166566
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils.
Mydel P; Shipley JM; Adair-Kirk TL; Kelley DG; Broekelmann TJ; Mecham RP; Senior RM
J Biol Chem; 2008 Apr; 283(15):9513-22. PubMed ID: 18178964
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil elastase activity compensates for a genetic lack of matrix metalloproteinase-9 (MMP-9) in leukocyte infiltration in a model of experimental peritonitis.
Kolaczkowska E; Grzybek W; van Rooijen N; Piccard H; Plytycz B; Arnold B; Opdenakker G
J Leukoc Biol; 2009 Mar; 85(3):374-81. PubMed ID: 19088179
[TBL] [Abstract][Full Text] [Related]
5. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Garratt LW; Sutanto EN; Ling KM; Looi K; Iosifidis T; Martinovich KM; Shaw NC; Kicic-Starcevich E; Knight DA; Ranganathan S; Stick SM; Kicic A;
Eur Respir J; 2015 Aug; 46(2):384-94. PubMed ID: 25929954
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinase-9-Generated COOH-, but Not NH
Gouwy M; De Buck M; Abouelasrar Salama S; Vandooren J; Knoops S; Pörtner N; Vanbrabant L; Berghmans N; Opdenakker G; Proost P; Van Damme J; Struyf S
Front Immunol; 2018; 9():1081. PubMed ID: 29915572
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticosteroids differentially regulate MMP-9 and neutrophil elastase in COPD.
Vlahos R; Wark PA; Anderson GP; Bozinovski S
PLoS One; 2012; 7(3):e33277. PubMed ID: 22413009
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
10. Internal Disulfide Bonding and Glycosylation of Interleukin-7 Protect Against Proteolytic Inactivation by Neutrophil Metalloproteinases and Serine Proteases.
Vandooren J; Pereira RVS; Ugarte-Berzal E; Rybakin V; Noppen S; Stas MR; Bernaerts E; Ganseman E; Metzemaekers M; Schols D; Proost P; Opdenakker G
Front Immunol; 2021; 12():701739. PubMed ID: 34276694
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
[TBL] [Abstract][Full Text] [Related]
12. Chronic E-Cigarette Use Increases Neutrophil Elastase and Matrix Metalloprotease Levels in the Lung.
Ghosh A; Coakley RD; Ghio AJ; Muhlebach MS; Esther CR; Alexis NE; Tarran R
Am J Respir Crit Care Med; 2019 Dec; 200(11):1392-1401. PubMed ID: 31390877
[No Abstract] [Full Text] [Related]
13. Secretory leukocyte proteinase inhibitor and elafin are resistant to degradation by MMP-8.
Henry MT; McMahon K; Costello C; Fitzgerald MX; O'Connor CM
Exp Lung Res; 2002 Mar; 28(2):85-97. PubMed ID: 11868825
[TBL] [Abstract][Full Text] [Related]
14. Proresolving Actions of Synthetic and Natural Protease Inhibitors Are Mediated by Annexin A1.
Vago JP; Tavares LP; Sugimoto MA; Lima GL; Galvão I; de Caux TR; Lima KM; Ribeiro AL; Carneiro FS; Nunes FF; Pinho V; Perretti M; Teixeira MM; Sousa LP
J Immunol; 2016 Feb; 196(4):1922-32. PubMed ID: 26800869
[TBL] [Abstract][Full Text] [Related]
15. BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis.
Kreideweiss S; Schänzle G; Schnapp G; Vintonyak V; Grundl MA
Inflamm Res; 2023 Aug; 72(8):1709-1717. PubMed ID: 37542002
[TBL] [Abstract][Full Text] [Related]
16. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma.
Simpson JL; Scott RJ; Boyle MJ; Gibson PG
Am J Respir Crit Care Med; 2005 Sep; 172(5):559-65. PubMed ID: 15901607
[TBL] [Abstract][Full Text] [Related]
17. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
Cipolla D; Zhang J; Korkmaz B; Chalmers JD; Basso J; Lasala D; Fernandez C; Teper A; Mange KC; Perkins WR; Sullivan EJ
Respir Res; 2023 May; 24(1):133. PubMed ID: 37198686
[TBL] [Abstract][Full Text] [Related]
19. Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response.
Majchrzak-Gorecka M; Majewski P; Grygier B; Murzyn K; Cichy J
Cytokine Growth Factor Rev; 2016 Apr; 28():79-93. PubMed ID: 26718149
[TBL] [Abstract][Full Text] [Related]
20. Protease-Antiprotease Imbalance in Bronchiectasis.
Oriano M; Amati F; Gramegna A; De Soyza A; Mantero M; Sibila O; Chotirmall SH; Voza A; Marchisio P; Blasi F; Aliberti S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
